Arboreal raises ₹230 crore Series A to scale functional food ingredient platform
Arboreal Bioinnovations has raised ₹230 crore in a Series A co-led by Omnivore and EAAA Alternatives, funding manufacturing, R&D and commercialization for its specialty food and nutraceutical ingredients business serving Indian consumer brands.
What happened
Arboreal Bioinnovations raised ₹230 crore in a Series A co-led by Omnivore and EAAA Alternatives to expand manufacturing, R&D and commercialization of
Key facts
- ₹230 crore
- More than doubled year-on-year growth
- More than 300 product launches
- Over 1,100 consumer brands and nutraceutical manufacturers
- Past 18 months
Why this matters
Strategic buyers should view Arboreal as an increasingly credible partnership or acquisition target, given its claimed reach across 1,100+ brands and 300+ product launches.
What to watch
- New plant commissioning dates, stated capacity and utilization ramp.
- Disclosure of annualized revenue, repeat-order share, gross margin and customer concentration.
- Multi-year supply contracts or co-development deals with major Indian FMCG, dairy, beverage or nutrition brands.
- Launches of proprietary ingredients, clinically backed formulations or branded premix platforms.
- FSSAI approvals, export certifications and entry into overseas markets.
- Evidence that Arboreal is replacing imports rather than primarily distributing third-party ingredients.
- Raw-material price movements and working-capital requirements as volumes scale.
- Commission or expand manufacturing capacity with food-safety, traceability and export-grade quality certifications.
- Build application-development centers focused on protein, gut health, sugar reduction, fortification and clean-label reformulation.
- Convert launch-support relationships into recurring supply agreements with anchor FMCG, D2C nutrition, dairy, beverage and bakery customers.
- Develop proprietary premixes and branded ingredient concepts that raise switching costs versus commodity ingredient distribution.
- Pursue regulatory validations, clinical substantiation and claims-support capabilities for nutraceutical and functional-food customers.
- Use the funding to deepen sourcing partnerships for botanical, fermentation-derived and agricultural raw materials, reducing input volatility.